Hemoglobin variants and determination of glycated hemoglobin (HbA1c)

W J Schnedl1, A Liebminger, R E Roller

  • 1Department of Internal Medicine, Karl-Franzens University School of Medicine, Auenbruggerplatz 15, A-8036 Graz, Austria. wolfgang.schnedl@kfunigraz.ac.at

Insights

Glycated hemoglobin (HbA1c) testing is crucial for diabetes management. However, hemoglobin variants can interfere, leading to inaccurate HbA1c results and potentially affecting patient care.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Hematology

Background:

  • Glycated hemoglobin (GHb) measurement is vital for assessing long-term glycemic control in diabetic patients.
  • Studies like DCCT and UKPDS confirm the link between glycemic control and diabetes complications.
  • Current testing excludes samples with hemoglobinopathies, lacking guidelines for Hb variants.

Purpose of the Study:

  • To review how hemoglobin variants interfere with glycated hemoglobin assays.
  • To highlight the potential for false HbA1c results due to these interferences.

Main Methods:

  • Literature review of studies on glycated hemoglobin determination.
  • Analysis of interference mechanisms of hemoglobin variants on HbA1c assays.

Main Results:

  • Hemoglobin variants are known to interfere with various glycated hemoglobin determination methods.
  • This interference can lead to inaccurate HbA1c values, misrepresenting glycemic control.

Conclusions:

  • The presence of hemoglobin variants poses a significant challenge for accurate HbA1c measurement.
  • Standardized guidelines are needed to address the comparability of samples with Hb variants to ensure reliable diabetes management.

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...